These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15099512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantifying the sequence-dependent species barrier between hamster and mouse prions.
    Lee LY, Chen RP.
    J Am Chem Soc; 2007 Feb 14; 129(6):1644-52. PubMed ID: 17243682
    [Abstract] [Full Text] [Related]

  • 3. [Prions and protein inhibitors of proteinases: structural analogies and their consequences. IV. The nature of the interspecies barrier of prion disease].
    Verevka SV.
    Ukr Biokhim Zh (1999); 2003 Feb 14; 75(1):115-20. PubMed ID: 14574749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deadly conformations--protein misfolding in prion disease.
    Horwich AL, Weissman JS.
    Cell; 1997 May 16; 89(4):499-510. PubMed ID: 9160742
    [No Abstract] [Full Text] [Related]

  • 7. Species-barrier-independent prion replication in apparently resistant species.
    Hill AF, Collinge J.
    APMIS; 2002 Jan 16; 110(1):44-53. PubMed ID: 12064255
    [Abstract] [Full Text] [Related]

  • 8. Interspecies transmission of prions.
    Afanasieva EG, Kushnirov VV, Ter-Avanesyan MD.
    Biochemistry (Mosc); 2011 Dec 16; 76(13):1375-84. PubMed ID: 22339593
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prion-like aggregates: infectious agents in human disease.
    Westermark GT, Westermark P.
    Trends Mol Med; 2010 Nov 16; 16(11):501-7. PubMed ID: 20870462
    [Abstract] [Full Text] [Related]

  • 11. Spongiform encephalopathies: insights from transgenic models.
    Aguzzi A, Brandner S, Fischer MB, Furukawa H, Glatzel M, Hawkins C, Heppner FL, Montrasio F, Navarro B, Parizek P, Pekarik V, Prinz M, Raeber AJ, Röckl C, Klein MA.
    Adv Virus Res; 2001 Nov 16; 56():313-52. PubMed ID: 11450305
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prion diseases: a nucleic-acid accomplice?
    Caughey B, Kocisko DA.
    Nature; 2003 Oct 16; 425(6959):673-4. PubMed ID: 14562085
    [No Abstract] [Full Text] [Related]

  • 16. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT, Lazo ND.
    Biochem J; 1999 Oct 15; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [Abstract] [Full Text] [Related]

  • 17. The prion theory: background and basic information.
    Riesner D.
    Contrib Microbiol; 2001 Oct 15; 7():7-20. PubMed ID: 11923938
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Yeast as a model for studying the prion and amyloid occurrence].
    Kryndushkin DS, Aleksandrov IM, Kushnirov VV, Ter-Avanesian MD.
    Ross Fiziol Zh Im I M Sechenova; 2004 May 15; 90(5):645-57. PubMed ID: 15341089
    [Abstract] [Full Text] [Related]

  • 20. [Tissue-specific cross-species transmission of prions].
    Béringue V, Vilotte JL, Laude H.
    Med Sci (Paris); 2012 May 15; 28(6-7):565-8. PubMed ID: 22805125
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.